Torrent Pharmaceuticals Limited announced its results for the quarter ended March 2025. The company registered a net profit of Rs. 498 crore as compared to Rs. 449 crore in the previous corresponding period.

The revenue witnessed a growth of 7.80 per cent on a year-on-year basis at Rs. 2,959 crore as compared to Rs. 2,745 crore in Q4 FY24. The company said that growth was fueled by growth throughout key geographies and therapeutic segments. 

On the operating front, EBITDA for the quarter was reported at Rs. 964 crore, 9.20 per cent  higher than Rs. 883 in Q4FY24. The company also informed that operating margins came in at 32.60 per cent against 32.20 per cent in the previous period under review.